Showing results (41-50 of 249) with videos related to
Sort By:
Pageof 25
Current Pharmaceutical Design|December 16, 2015
Tryptophan Metabolites and Their Impact on Multiple Sclerosis ProgressionJens O Watzlawik, Bharath Wootla, Moses RodriguezInternational Immunology|March 29, 2003
HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesisMeenakshi Khare, Moses Rodriguez, Chella S DavidNeurobiology of Disease|August 5, 2006
Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1betaCharles L Howe, Sonia Mayoral, Moses RodriguezExpert Review of Neurotherapeutics|May 14, 2019
Glial cells as therapeutic targets in progressive multiple sclerosisBrandon Wilbanks, L J Maher, Moses RodriguezCurrent Pharmaceutical Design|February 23, 2016
Tryptophan Catabolites and Their Impact on Multiple Sclerosis ProgressionJens O Watzlawik, Bharath Wootla, Moses RodriguezAdvances in Experimental Medicine and Biology|January 18, 2017
Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis ProgressionBurcu Zeydan, Moses Rodriguez, Orhun H KantarciTrends in Immunology|October 29, 2002
Growth factor treatment of demyelinating disease: at last, a leap into the lightRichard M Ransohoff, Charles L Howe, Moses RodriguezNeurology|April 8, 2009
Invited article: human natural autoantibodies in the treatment of neurologic diseaseMoses Rodriguez, Arthur E Warrington, Larry R PeaseNeurobiology of Disease|November 23, 2006
Absence of perforin expression confers axonal protection despite demyelinationCharles L Howe, Jaimie D Adelson, Moses RodriguezNeurobiology of Disease|August 22, 2006
Disrupted spatial memory is a consequence of picornavirus infectionEric J Buenz, Moses Rodriguez, Charles L HowePageof 25